摘要
推荐理由：支气管肺癌（肺癌）是世界上发病率及病死率最高的恶性肿瘤，每年死亡人数达140W，占所有恶性肿瘤死亡人数的18％。但是，由于我国约75％的肺癌患者在诊断时已属晚期，5年生存率仅约15．6％。
同被引文献19
-
1Goldstraw P, Crowley J, Chansky K, et al. The IASLC lung cancer staging project" proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours[J]. Journal of Thorac- ic Oncology, 2007,2(8) :706-714.
-
2Austin JH, Mailer NL, Friedman PJ, etal. Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society[J]. Radiology, 1996,200 (2) :327-331.
-
3Ost D, Fein AM, Feinsilver SH. Clinicalpractice. The solitary pulmonarynodule[J]. N Engl J Med, 2003,348 (25): 2535- 2542.
-
4MacMahon H, Austin JH, Gamsu G, etal. Guidelines for man- agement of small pulmonary nodules detected on CT scans: ax- ent from the Fleischner Society[J]. Radiology, 2005, 2371 395-400.
-
5National Lung Screening Trial Research Team, Aberle DR, Ad- ams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening[J]. N Engl J Med,2011, 365 (5) :395-409.
-
6Carillo GA, V6zquez JE, Villar AF. Prevalence of benign pul- monary lesions excised for suspicion of malignancy: could it re- fleet a quality management index of indeterminate lung lesions [J]? Korean J Thorac Cardiovasc Surg, 2014,47(5) :458-464.
-
7Asija A, Maniekam R, Aronow WS,etal. Pulmonary nodule: a comprehensive review and update [J]. Hosp Pratt (1995), 2014,42(3) :7-16.
-
8Horeweg N, van Rosmalen J, Heuvelmans MA, et al. Lung cancer probability in patients with CT-detected pulmonary nod- ules: a prespecified analysis of data from the NELSON trial of low-dose CT screening[J]. Lancet Oncol, 2014,15 (12) : 1332- 1341.
-
9Swensen SJ, Jett JR, Hartman TE, etal. CT screening for lung cancer: five-year prospective experience[J]. Radiology, 2005, 235(1) :259-265.
-
10Ma J, Ward EM, Smith R, Jemal A. Annual number of lung cancer deaths potentially avertable by screening in the United States[J]. Cancer, 2013,119(7) :1381-1385.
-
1何裕隆.胃肠间质瘤外科诊治共识和争议[J].中华胃肠外科杂志,2013,16(3):201-203. 被引量：20
-
2miR-223有望成为评估弥漫性大B细胞淋巴瘤预后新标记[J].中华医学信息导报,2012,27(14):9-9.
-
3子宫内膜癌分型研究进展[J].中华医学信息导报,2016,0(14):9-9.
-
4中国早期结直肠癌及癌前病变筛查与诊治共识（2014年，重庆）[J].中华消化内镜杂志,2015,32(2):69-85. 被引量：100
-
5李鹏,王拥军,陈光勇,许昌芹.中国早期结直肠癌及癌前病变筛查与诊治共识[J].中国实用内科杂志,2015,35(3):211-227. 被引量：131
-
6李鹏,王拥军,陈光勇,许昌芹.中国早期结直肠癌及癌前病变筛查与诊治共识[J].中国医刊,2015,50(2):14-30. 被引量：38
-
7林岩松,张彬,梁智勇,牛丽娟,何霞云,陈立波,丁勇,关海霞,高再荣,侯晓荣,李雪娜,李小毅,李玉军,李玉明,罗渝昆,马庆杰,孙文海,王任飞,张波,安锐,樊友本,郭晔,郭朱明,黄钢,黄慧强,黄韬,蒋宁一,匡安仁,李方,李思进,李亚明,谭建,邢小平,赵家军.复发转移性分化型甲状腺癌诊治共识[J].中国癌症杂志,2015,25(7):481-496. 被引量：46
-
8中国早期食管鳞状细胞癌及癌前病变筛查与诊治共识（2015年·北京）[J].中华内科杂志,2016,55(1):73-85. 被引量：21
-
9无,李鹏,陈光勇,王拥军,许昌芹.中国早期食管鳞状细胞癌及癌前病变筛查与诊治共识(2015年·北京)[J].中国医刊,2016,51(1):17-31. 被引量：17
-
10李玉升.晚期结直肠癌的规范化疗[J].肿瘤研究与临床,2007,19(10):649-652. 被引量：1
